Catalyst Wire Dossier Catalyst Wire Dossier

Foralumab

Foralumab · Tiziana Life Sciences Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Foralumab, covering 2025-03-17 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease [Phase 2]

See pricing